Cargando…
Comment on: Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Reply
Autores principales: | Pego-Reigosa, José M, Rúa-Figueroa Fernández de Larrinoa, Íñigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825334/ https://www.ncbi.nlm.nih.gov/pubmed/34605908 http://dx.doi.org/10.1093/rheumatology/keab603 |
Ejemplares similares
-
Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021) -
Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply
por: Esen, Idil, et al.
Publicado: (2022) -
Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate: reply
por: Stamatis, Pavlos, et al.
Publicado: (2021) -
Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply
por: Smeele, Hieronymus T W, et al.
Publicado: (2021) -
Comment on: The neglected and untreated pains of CRMO and SAPHO syndrome
por: Leerling, Anne T, et al.
Publicado: (2022)